News List

Nature Biotechnology | Antibody Drug Conjugators (ADCs) : ushering in a new era of precision cancer therapy
2024-03-16

Recent studies have shown that by improving the linking technology and developing novel drug carrier

The oral version of Semaglutide was approved for domestic market, and clinical results showed that it can effectively reduce blood sugar and lose weight
2024-02-06

On January 26, 2024, the official website of the State Food and Drug Administration showed that the

Semaglutide has a real rival! Lilly's strongest weight-loss drug, tilpotide is approved by the FDA
2023-12-01

The FDA approved Tizepatide, developed by Eli Lilly and Company, as a weight loss drug (trade name Z

It can restore 80% hair growth, and Pfizer's new drug for alopecia areata was approved for sale in China, which can treat adolescent alopecia areata
2023-11-02

On October 19, 2023, the official website of China's State Drug Administration showed that it ap

155 million dollars! Hengrui Medicine has another innovative drug to go to sea
2023-10-10

Hengray Pharmaceutical announced that it has entered into an agreement with Dr. Reddy's Laborato

Bagel Biologics receives approval to initiate Phase I clinical trial of TCR cell therapy
2023-09-13

On September 9, 2023, Biosyngen Pte Ltd (hereinafter referred to as "Biosyngen") announced

Researchers at Zhejiang University School of Medicine have revealed that the concept of targeting DDK can improve the efficacy of immunotherapy for liver cancer
2023-08-30

Hepatocellular carcinoma is a common and highly aggressive tumor that has been recognized as the sev

On July 14, Bojian's listing application for tofersen injection was accepted.
2023-07-31

On April 25, 2023, the FDA accelerated approval of the antisense oligonucleotide therapy tofersen (Q

The annual bleeding rate of patients was reduced by 71%, and Pfizer's marketing application for hemophilia gene therapy was accepted by the FDA
2023-07-04

Pfizer, Inc. (NYSE: PFE) today announced that the FDA has accepted a biologics license application (

FDA approves First repeatable drug gene Therapy, $630,000 a Year, for 'most painful diseases'
2023-05-23

On May 19, 2023, the FDA approved Beremagene Geperpavec (B-VEC), a topical gene therapy based on the